Reuters logo
8 天前
BRIEF-Syndax Pharmaceuticals Q2 loss per share $0.70
2017年8月10日 / 晚上8点35分 / 8 天前

BRIEF-Syndax Pharmaceuticals Q2 loss per share $0.70

Aug 10 (Reuters) - Syndax Pharmaceuticals Inc

* Syndax Pharmaceuticals reports second quarter 2017 financial results and provides clinical and business update

* Q2 loss per share $0.70

* Q2 earnings per share view $-0.83 -- Thomson Reuters I/B/E/S

* Syndax Pharmaceuticals Inc - ‍for Q3 research and development expenses are expected to be $12.0 to $14.0 million​

* Syndax Pharmaceuticals Inc - ‍for full year 2017, research and development expenses are expected to be $46.0 to $51.0 million​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below